UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Alimentary pharmacology & therapeutics, 2011-12, Vol.34 (11‐12), p.1269-1281

2011

Link zum Volltext

Verfügbarkeit prüfen

Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Alimentary pharmacology & therapeutics, 2013-06, Vol.37 (11), p.1084-1092

2013

Link zum Volltext

Verfügbarkeit prüfen

Relative importance of abnormalities of CCK and 5‐HT (serotonin) in Giardia‐induced post‐infectious irritable bowel syndrome and functional dyspepsia

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (8), p.883-891

2010

Link zum Volltext

Verfügbarkeit prüfen

Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implications

Alimentary pharmacology & therapeutics, 2009-01, Vol.29 (2), p.145-160

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of frequent consumption of a Lactobacillus casei‐containing milk drink in Helicobacter pylori‐colonized subjects

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.429-435

2003

Link zum Volltext

Verfügbarkeit prüfen

Review article: bismuth-based therapy for Helicobacter pylori eradication in children

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (9), p.1010-1026

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1‐week regimen of proton pump inhibitor, amoxicillin and clarithromycin

Alimentary pharmacology & therapeutics, 2003-01, Vol.17 (2), p.259-264

2003

Link zum Volltext

Verfügbarkeit prüfen

Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24‐h pH monitoring

Alimentary pharmacology & therapeutics, 1999-02, Vol.13 (2), p.155-162

1999

Link zum Volltext

Verfügbarkeit prüfen

Low‐dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication

Alimentary pharmacology & therapeutics, 2004-01, Vol.19 (1), p.89-93

2004

Link zum Volltext

Verfügbarkeit prüfen

Cure of Helicobacter pylori infection does not improve symptoms in non‐ulcer dyspepsia patients—a double‐blind placebo‐controlled study

Alimentary pharmacology & therapeutics, 2000-03, Vol.14 (3), p.317-324

2000

Link zum Volltext

Verfügbarkeit prüfen

Furazolidone combination therapies for Helicobacter pylori infection in the United States

Alimentary pharmacology & therapeutics, 2000-02, Vol.14 (2), p.211-215

2000

Link zum Volltext

Verfügbarkeit prüfen

Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19

Alimentary pharmacology & therapeutics, 2005-02, Vol.21 (4), p.491-497

2005

Link zum Volltext

Verfügbarkeit prüfen

Gastric mucosal inflammatory responses to Helicobacter pylori

Alimentary pharmacology & therapeutics, 1996-04, Vol.10 (Sup1), p.29-37

Crabtree, JE

1996

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis

Alimentary pharmacology & therapeutics, 2002-08, Vol.16 (8), p.1491-1501

2002

Link zum Volltext

Verfügbarkeit prüfen

Furazolidone‐containing short‐term triple therapies are effective in the treatment of Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 1999-03, Vol.13 (3), p.317-322

1999

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of invasive and non‐invasive tests for the diagnosis of Helicobacter pylori infection in Chinese

Alimentary pharmacology & therapeutics, 2001-04, Vol.15 (4), p.505-511

2001

Link zum Volltext

Verfügbarkeit prüfen

Review article: symptom improvement through eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia

Alimentary pharmacology & therapeutics, 1996-12, Vol.10 (6), p.843-850

1996

Link zum Volltext

Verfügbarkeit prüfen

What is the role of serology in assessing Helicobacter pylori eradication?

Alimentary pharmacology & therapeutics, 2003-09, Vol.18 (6), p.635-639

2003

Link zum Volltext

Verfügbarkeit prüfen

The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine

Alimentary pharmacology & therapeutics, 1999-06, Vol.13 (6), p.731-740

1999

Link zum Volltext

Verfügbarkeit prüfen

The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration

Alimentary pharmacology & therapeutics, 1996-04, Vol.10 (Sup1), p.57-64

Mobley, HL

1996

Link zum Volltext

Verfügbarkeit prüfen

Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcer

Alimentary pharmacology & therapeutics, 1997-10, Vol.11 (5), p.943-952

1997

Link zum Volltext

Verfügbarkeit prüfen

Review article : urea breath tests for detecting Helicobacter pylori

Alimentary pharmacology & therapeutics, 1997-08, Vol.11 (4), p.641-649

1997

Link zum Volltext

Verfügbarkeit prüfen

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence

Alimentary pharmacology & therapeutics, 1996-06, Vol.10 (3), p.251-262

1996

Link zum Volltext

Verfügbarkeit prüfen

Effects of rebamipide, a gastro‐protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double‐blind placebo‐controlled multicentre trial

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (s1), p.146-152

2003

Link zum Volltext

Verfügbarkeit prüfen

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

Alimentary pharmacology & therapeutics, 2000-03, Vol.14 (3), p.299-303

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 305

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Zeitschrift / SerieAlimentary Pharmacology & Therapeutics

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(305)

Publikationsform

Artikel
(305)

Sprache

Englisch
(305)
Japanisch
(74)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(305)
Humans
(273)
Gastroenterology & Hepatology
(271)
Life Sciences & Biomedicine
(271)
Pharmacology & Pharmacy
(271)
Science & Technology
(271)
Pharmacology. Drug Treatments
(226)
Male
(214)
Digestive System
(206)
Female
(204)
Adult
(178)
Middle Aged
(178)
Aged
(131)
Helicobacter Infections - Drug Therapy
(127)
Gastroenterology. Liver. Pancreas. Abdomen
(117)
Helicobacter Pylori
(111)
Drug Therapy, Combination
(76)
Gastroenterology
(70)
Hepatology
(70)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library
(305)
IngentaConnect Journals
(305)
Wiley Online Library
(305)
Electronic Journals Library - Freely accessible e-journals
(305)
Journals@Ovid Full Text
(305)
MEDLINE
(285)
Ingenta
(32)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Relative importance of abnormalities of CCK and 5‐HT (serotonin) in Giardia‐induced post‐infectious irritable bowel syndrome and functional dyspepsia

Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implications

Effect of frequent consumption of a Lactobacillus casei‐containing milk drink in Helicobacter pylori‐colonized subjects

Review article: bismuth-based therapy for Helicobacter pylori eradication in children

Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1‐week regimen of proton pump inhibitor, amoxicillin and clarithromycin

Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24‐h pH monitoring

Low‐dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication

Cure of Helicobacter pylori infection does not improve symptoms in non‐ulcer dyspepsia patients—a double‐blind placebo‐controlled study

Furazolidone combination therapies for Helicobacter pylori infection in the United States

Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19

Gastric mucosal inflammatory responses to Helicobacter pylori

Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis

Furazolidone‐containing short‐term triple therapies are effective in the treatment of Helicobacter pylori infection

An evaluation of invasive and non‐invasive tests for the diagnosis of Helicobacter pylori infection in Chinese

Review article: symptom improvement through eradication of Helicobacter pylori in patients with non‐ulcer dyspepsia

What is the role of serology in assessing Helicobacter pylori eradication?

The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine

The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration

Short‐course therapy with amoxycillin–clarithromycin triple therapy for 10 days (ACT‐10) eradicates Helicobacter pylori and heals duodenal ulcer

Review article : urea breath tests for detecting Helicobacter pylori

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence

Effects of rebamipide, a gastro‐protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double‐blind placebo‐controlled multicentre trial

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

Aktive Filter

Suchergebnisse filtern